<DOC>
	<DOCNO>NCT01573039</DOCNO>
	<brief_summary>CMV disease challenge success renal transplantation . Recently , investigator analyze data 792 renal transplant recipient perform hospital 1999 2005 . After usual exclusion , 663 patient analyze . This population show incidence CMV disease stable occur approximately 20-22 % patient invasive disease approximately 5 % every year . In seronegative patient receive anti-lymphocyte ( AL ) , CMV prophylaxis , do ganciclovir 90 day routine majority transplant center . In seropositive patient without associate risk factor ( use AL ) universal prophylaxis do . Rather , group , early diagnosis , detection antigenemia viremia quantitative PCR , perform patient show symptom compatible CMV disease . In investigator analysis incidence CMV disease seropositive patient around 16 % . These patient usually hospitalize treated GCV IV 14-21 day . This lead additional cost admission , biopsy diagnosis disease invasion , etc . Besides cost , survival graft long run low patient CMV disease without CMV , particularly associate acute rejection . In recent year , monitor viremia ( PCR / antigenemia ) preemptive treatment reach substantial value , increasingly suggest . Patients detection viremia progressive value detect would treat outpatient disease develops . To turn hypothesis reality , urgent need define cutoff value CMV-PCR detection develop CMV disease .</brief_summary>
	<brief_title>Cut Off Diagnosis Cytomegalovirus ( CMV ) Disease Serum-positive Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<criteria>Patients 14 year younger 75 year Seropositive CMV ( IgG ) Kidney transplant recipient Patients receive antilymphocyte induction Patients organ transplant double</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Kidney transplantation</keyword>
	<keyword>PCR quantitative</keyword>
	<keyword>cytomegalovirus</keyword>
	<keyword>antigenemia</keyword>
</DOC>